COVID-19 Tip Sheet: Story Ideas From Johns Hopkins

Johns Hopkins Medicine

The following are various story ideas regarding the COVID-19 illness. To interview Johns Hopkins experts on these topics or others, contact



In a time where limited contact and social distancing is imperative, telemedicine is proving to be a valuable staple of the future of health care. Led by Rebecca Canino, administrative director for telemedicine, and Brian Hasselfeld, M.D., assistant medical director of Johns Hopkins digital health innovations, Johns Hopkins Medicine has turned on telemedicine capabilities systemwide in response to the pandemic. The technology means all Johns Hopkins patients registered in the Epic electronic medical system will be able to access remote care. Keeping patients at home instead of in hospitals or clinics, when appropriate, will slow the spread of the virus that causes COVID-19, enable continuity of care between our providers and patients, and protect at-risk groups such as geriatric and oncology patients. Canino and Hasselfeld can discuss details about activating a telemedicine response to COVID-19.



Across the nation, COVID-19 has given children a longer spring break from school than expected. For parents searching desperately for things to keep their youngsters busy with besides an endless stream of video games and TV watching, Shannon Barnett, M.D., assistant professor of psychiatry and behavioral sciences at Johns Hopkins University School of Medicine, may have just what Mom and Dad need. She can discuss her flyer, “Schools are Closed. Now What,” a tool that helps families schedule activities, exercise, projects and even chores so that Mr. Boredom stays far away, parents maintain their sanity and children have less anxiety about the pandemic. Fun ideas from the piece include: have a dance party, cook a meal together and make a video about how the family is staying safe from COVID-19.



In addition to older adults, people with certain pre-existing conditions may be more at risk for serious complications from COVID-19. In particular, pulmonologist Enid Neptune, M.D., can discuss how people with asthma or other chronic lung disorders may be more susceptible. Cardiologist Erin Michos, M.D., M.H.S., can discuss why people with heart and vascular conditions are at risk. Rehabilitation psychologist Abbey Hughes, Ph.D., M.A., can address how patients with autoimmune diseases such as multiple sclerosis need to take additional precautions against infection.



Viruses such as the one that causes COVID-19 infect the cells that line the lungs, intestine and blood vessels by latching onto a protein known as ACE2 and hitchhiking their way into the cell. In theory, the more ACE2 the cells make, the easier it is for the virus to get inside. People with diabetes and high blood pressure are often treated with medications that raise ACE2 levels, such as ACE inhibitors and angiotensin II type-I receptor blockers that lower blood pressure by relaxing blood vessels. Glitazones, diabetes drugs that help lower blood sugar, also increase ACE2 levels. Obesity and diabetes can themselves lead to elevated ACE2 levels independent of drug treatment. As a result, some have questioned whether people on these medications may be more susceptible infection from the virus that causes COVID-19. Basic science researcher and cardiologist David Kass, M.D., can discuss what we know about this and what patients should do if they are on one of these medications.



COVID-19 has greatly impacted daily life for communities worldwide and has put many communities at risk. The virus has infected thousands of patients in the United States. Routine doctors’ appointments are being postponed, retail stores and restaurants have closed their doors, and large public events have been canceled in an effort to stop the spread of the virus. While many are able to seek the care they need to address the illness, some people are in communities that lack basic access to health care facilities that are equipped to treat them. This is becoming a growing issue in America. Lisa Cooper, M.D., M.P.H., can discuss how COVID-19 is affecting these populations.


For more information about coronavirus disease (COVID-19) from Johns Hopkins Medicine, visit For information on coronavirus disease (COVID-19) from around the Johns Hopkins enterprise, including from the Johns Hopkins University Bloomberg School of Public Health and The Johns Hopkins University, visit


Filters close

Showing results

110 of 1996
Newswise: Daya Bay Reactor Experiment Continues to Generate Data
Released: 29-May-2020 10:00 AM EDT
Daya Bay Reactor Experiment Continues to Generate Data
Lawrence Berkeley National Laboratory

Largely unaffected by the pandemic, the Daya Bay reactor neutrino experiment in Shenzen, China, has continued to pump data to remote supercomputers for analyses.

Newswise:Video Embedded newswise-expert-panels-on-covid-19-pandemic-notable-excerpts-quotes-and-videos-available
Released: 29-May-2020 9:50 AM EDT
Newswise Expert Panels on COVID-19 Pandemic: Notable excerpts, quotes and videos available

Newswise is hosting a series of Expert Panels discussion unique aspects of the COVID-19 Outbreak. This tip sheet includes some notable quotes from the panelists.

Newswise: COVID-19 Healthcare Coalition Launches COVID-19 Decision Support Dashboard
Released: 29-May-2020 9:00 AM EDT
COVID-19 Healthcare Coalition Launches COVID-19 Decision Support Dashboard
COVID-19 Healthcare Coalition

The new COVID-19 Decision Support Dashboard synthesizes large amounts of complex, essential data into easy-to-use key findings for public and private-sector leaders navigating the “reopening” of communities and businesses.

Released: 29-May-2020 9:00 AM EDT
Online, or On-Campus? Returning to School After COVID: Newswise Live Event for June 4, 2PM EDT

Will schools reopen in the fall? If schools remain closed, what will be the impact on students’ education, long-term? How has the pandemic already impacted students, from elementary through higher ed; how are schools at all levels adapting to teaching virtually, and how to safely return to teaching in person - June 4, 2020 from 2-3 PM EDT

Released: 29-May-2020 6:50 AM EDT
Those with IDD more likely to die from COVID-19, study shows
Syracuse University

A new study published recently in ScienceDirect by researchers from Syracuse University and SUNY Upstate Medical University shows that people with intellectual and developmental disabilities (IDD) are more likely to die from COVID-19 than those without IDD.

Newswise: Invention by a Finnish start-up speeds up coronavirus testing
Released: 29-May-2020 6:25 AM EDT
Invention by a Finnish start-up speeds up coronavirus testing
Aalto University

An Aalto University spinoff company has come up with a way to use existing lab microscopes in a completely new and much more effective way with their innovation of nanocoated glass. While this is very relevant to covid19 research, it holds great promise for many other viruses and diseases

Newswise: Tourism: what’s our new normal?
Released: 29-May-2020 6:20 AM EDT
Tourism: what’s our new normal?
University of South Australia

After months of lockdown, it’s no surprise that people are itching to get out and about. But with ongoing debates about how and when to open Australia’s state and territory borders, it’s hard to know what to expect.

Newswise: Calibrated approach to AI and deep learning models could more reliably diagnose and treat disease
Released: 29-May-2020 6:05 AM EDT
Calibrated approach to AI and deep learning models could more reliably diagnose and treat disease
Lawrence Livermore National Laboratory

In a recent preprint (available through Cornell University’s open access website arXiv), a team led by a Lawrence Livermore National Laboratory computer scientist proposes a novel deep learning approach aimed at improving the reliability of classifier models designed for predicting disease types from diagnostic images, with an additional goal of enabling interpretability by a medical expert without sacrificing accuracy. The approach uses a concept called confidence calibration, which systematically adjusts the model’s predictions to match the human expert’s expectations in the real world.

Newswise: Researchers Develop Experimental Rapid COVID-19 Test Using Innovative Nanoparticle Technique
Released: 28-May-2020 6:35 PM EDT
Researchers Develop Experimental Rapid COVID-19 Test Using Innovative Nanoparticle Technique
University of Maryland Medical Center

Scientists from the University of Maryland School of Medicine (UMSOM) developed an experimental diagnostic test for COVID-19 that can visually detect the presence of the virus in 10 minutes. It uses a simple assay containing plasmonic gold nanoparticles to detect a color change when the virus is present. The test does not require the use of any advanced laboratory techniques, such as those commonly used to amplify DNA, for analysis. The authors published their work last week in the American Chemical Society’s nanotechnology journal ACS Nano.

Showing results

110 of 1996